Ligand Pharmaceuticals Incorporated ( LGND ) M&A Call April 27, 2026 8:00 AM EDT
Company Participants
Melanie Herman
Todd Davis - CEO & Director
Octavio Espinoza - Chief Financial Officer
Lauren Hay
Conference Call Participants
Matthew Hewitt - Craig-Hallum Capital Group LLC, Research Division
Annabel Samimy - Stifel, Nicolaus & Company, Incorporated, Research Division
Yigal Nochomovitz - Citigroup Inc., Research Division
Joseph Pantginis - H.C. Wainwright & Co, LLC, Research Division
Jason Zemansky
Lawrence Solow - CJS Securities, Inc.
Presentation
Operator
Ladies and gentlemen, thank you for standing by. My name is Krista, and I will be your conference operator today. At this time, I would like to welcome everyone to Ligand Pharmaceuticals to acquire XOMA Royalty. [Operator Instructions]
I would now like to turn the conference over to Melanie Herman, Head of Investor Relations.…